30 days FREE from Class 9 to DropperRegister free

Assertion (A): A patient of ADA deficiency undergoing treatment for gene therapy requires periodic infusion of genetically engineered lymphocytes. Reason (R): Lymphocytes are immortal.

CBSE 2023 BoardBiologyBiotechnology and its Applications · Gene therapy
  • A. Both Assertion (A) and Reason (R) are true and Reason (R) is the correct explanation of Assertion (A).
  • B. Both Assertion (A) and Reason (R) are true, but Reason (R) is not the correct explanation of Assertion (A).
  • C. Assertion (A) is true, but Reason (R) is false.
  • D. Assertion (A) is false, but Reason (R) is true.
Show answer & explanation

Answer: (C) Assertion (A) is true, but Reason (R) is false.

Explanation

The assertion is true: in ADA-deficiency gene therapy, genetically engineered lymphocytes must be infused periodically. The reason is false: these lymphocytes are not immortal. (CBSE Class 12 Biology 2023)

Practise every Biotechnology and its Applications question with a timer

Chapter tests, full NEET mocks, your score and weak topics — 70,000+ questions on YNeet.

Start free for 30 days

No payment, no card. Sign up in 30 seconds.

For Class 11, 12 and droppers, see what the YNeet NEET online course includes.

More Biotechnology and its Applications questions

All free Biotechnology and its Applications PYQs →